Amy Guo, PhD

Senior Director, Health Outcome Research
Ferring Pharmaceuticals

Disclosure(s): Ferring Pharmaceuticals: Employee

Poster(s):

• 522 - Significant Improvement in Health-Related Quality of Life (HRQL) with RBX2660: Results from a Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides Difficile Infection (PUNCH CD3)
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET